Pediatric Blood & Cancer, 1545-5009
Journal
Publications
- 2021
The Global COVID-19 Observatory and Resource Center for Childhood Cancer: A response for the pediatric oncology community by SIOP and St. Jude Global
& 5 others, , 24 Feb 2021, In: Pediatric Blood & Cancer. p. e28962Research output: Contribution to journal › Article › peer-review
- 2020
- Published
Pediatric cancer research: Surviving COVID-19
Pamela Kearns, 18 Jun 2020, In: Pediatric Blood & Cancer. p. e28435Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
The COVID-19 pandemic: a rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI and St Jude Global
Pamela Kearns, 13 May 2020, In: Pediatric Blood & Cancer. e28409.Research output: Contribution to journal › Article › peer-review
- 2019
- Published
Catalytic inhibition of KDM1A in Ewing sarcoma is insufficient as a therapeutic strategy.
Susanne Gatz, Sep 2019, In: Pediatric Blood & Cancer. 66, 9, 9 p., e27888.Research output: Contribution to journal › Article › peer-review
- Published
Long-term analysis of children with metastatic neuroblastoma treated in the ENSG5 randomised clinical trial
Pamela Kearns, 1 Apr 2019, In: Pediatric Blood & Cancer. 66, 4, 5 p., e27565.Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Challenges and opportunities in the care of survivors of adolescent and young adult (AYA) cancers
Michael Hawkins, 28 Feb 2019, In: Pediatric Blood & Cancer. 66, 6, e27668.Research output: Contribution to journal › Review article › peer-review
- 2018
- E-pub ahead of print
The utility of routine surveillance screening with magnetic resonance imaging to detect tumour recurrence/progression in children with high-grade central nervous system tumours
Simon Stevens, Caroline Main, Andrew Peet, Keith Wheatley, Pamela Kearns & Jayne Wilson, 8 Nov 2018, In: Pediatric Blood & Cancer. 9 p., e27509.Research output: Contribution to journal › Article › peer-review
- 2017
- E-pub ahead of print
Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study)
Keith Wheatley, 23 Jan 2017, In: Pediatric Blood & Cancer.Research output: Contribution to journal › Article › peer-review
- 2016
- E-pub ahead of print
A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia
Pamela Kearns & 1 others, , 1 Dec 2016, In: Pediatric Blood & Cancer.Research output: Contribution to journal › Article › peer-review
- 2015
- Published
Chemotherapy responsiveness in a patient with multiply relapsed ameloblastic fibro-odontosarcoma of the maxilla
Susanne Gatz, Nov 2015, In: Pediatric Blood & Cancer. 62, 11, p. 2029-2032 4 p.Research output: Contribution to journal › Article › peer-review